Pastré Jean, Prévotat Anne, Tardif Catherine, Langlois Carole, Duhamel Alain, Wallaert Benoit
Université Lille 2 et Clinique des Maladies Respiratoires, CRCM Hôpital Calmette, CHRU Lille, France.
BMC Pulm Med. 2014 Apr 30;14:74. doi: 10.1186/1471-2466-14-74.
Adult patients with cystic fibrosis (CF) frequently have reduced exercise tolerance, which is multifactorial but mainly due to bronchial obstruction. The aim of this retrospective analysis was to determine the mechanisms responsible for exercise intolerance in patients with mild-to-moderate or severe disease.
Cardiopulmonary exercise testing with blood gas analysis at peak exercise was performed in 102 patients aged 28 ± 11 years: 48 patients had severe lung disease (FEV1 < 50%, group 1) and 54 had mild-to-moderate lung disease (FEV1 ≥ 50%, group 2). VO2 peak was measured and correlated with clinical, biological, and functional parameters.
VO2 peak for all patients was 25 ± 9 mL/kg/min (65 ± 21% of the predicted value) and was < 84% of predicted in 82% of patients (100% of group 1, 65% of group 2). VO2 peak was correlated with body mass index, C-reactive protein, FEV1, FVC, RV, DLCO, VE/VCO2 peak, VD/VT, PaO2, PaCO2, P(A-a)O2, and breathing reserve. In multivariate analysis, FEV1 and overall hyperventilation during exercise were independent determinants of exercise capacity (R(2) = 0.67). FEV1 was the major significant predictor of VO2 peak impairment in group 1, accounting for 31% of VO2 peak alteration, whereas excessive overall hyperventilation (reduced or absent breathing reserve and VE/VCO2) accounted for 41% of VO2 alteration in group 2.
Exercise limitation in adult patients with CF is largely dependent on FEV1 in patients with severe lung disease and on the magnitude of the ventilatory response to exercise in patients with mild-to-moderate lung disease.
成年囊性纤维化(CF)患者的运动耐量常常降低,其原因是多方面的,但主要是由于支气管阻塞。这项回顾性分析的目的是确定轻至中度或重度疾病患者运动不耐受的机制。
对102名年龄为28±11岁的患者进行了心肺运动试验,并在运动峰值时进行血气分析:48名患者患有严重肺部疾病(第1组,第1秒用力呼气容积[FEV1]<50%),54名患者患有轻至中度肺部疾病(第2组,FEV1≥50%)。测量了峰值摄氧量(VO2峰值),并将其与临床、生物学和功能参数进行关联。
所有患者的VO2峰值为25±9毫升/千克/分钟(为预测值的65±21%),82%的患者(第1组的100%,第2组的65%)低于预测值的84%。VO2峰值与体重指数、C反应蛋白、FEV1、用力肺活量(FVC)、残气量(RV)、一氧化碳弥散量(DLCO)、呼出气体中二氧化碳与吸入气体中氧气的比值(VE/VCO2峰值)、死腔量与潮气量比值(VD/VT)、动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)、肺泡-动脉血氧分压差[P(A-a)O2]和呼吸储备相关。在多因素分析中,FEV1和运动期间的总体过度通气是运动能力的独立决定因素(R(2)=0.67)。FEV1是第1组VO2峰值受损的主要显著预测因素,占VO2峰值改变的31%,而第2组中总体过度通气过多(呼吸储备降低或缺乏以及VE/VCO2)占VO2改变的41%。
成年CF患者的运动受限在严重肺部疾病患者中很大程度上取决于FEV1,在轻至中度肺部疾病患者中则取决于运动时通气反应的程度。